Basic Information
Fetcroja
Regulatory Information
EMEA/H/C/004829
Authorised
April 23, 2020
10
July 19, 2024
Company Information
the netherlands
Herengracht 464 1017 CA Amsterdam
SHIONOGI B.V.
Active Substances Detail
cefiderocol sulfate tosilate
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Fetcroja is indicated for the treatment of infections due to aerobic Gram-negative organisms in adults with limited treatment options (see sections 4.2, 4.4 and 5.1). Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Overview Summary
Fetcroja is an antibiotic used in adults to treat infections caused by bacteria classed as aerobic Gram-negative bacteria. It is for use when other treatments might not work. Fetcroja contains the active substance cefiderocol.